Recent YSCC Discoveries

The Yale Department of Internal Medicine is proud to welcome three new professors: Lydia Aoun-Barakat, MD; Tracy Battaglia, MD, MPH; and Priti Kumar, PhD.

Amos Espinosa, a PhD candidate in the Krause Laboratory and a medical research scholar in the Yale Combined Program in the Biological and Biomedical Sciences, has been awarded an F31 NRSA Fellowship from the National Cancer Institute

A team led by John Tsang, PhD, MMath, Anthony N. Brady Professor of Immunobiology, has been awarded a £4,200,000 grant from the Advanced Research + Invention Agency (ARIA) for a project that aims to decode and engineer coordinated immune responses that rapidly clear viruses in an effort to minimize viral spread and immunopathology.

Yale School of Medicine (YSM) was awarded a $1.69 million gift from Coefficient Giving to advance the development of an effective parasite vaccine led by Richard “Rick” Bucala, YC ’79, MS ’79, MD, PhD, chief of the Section of Rheumatology, Allergy, and Immunology, Waldemar Von Zedtwitz Professor of Medicine (Rheumatology), and professor of pathology and of epidemiology (microbial diseases).

This summer, we saw a first-of-its-kind cross-sector collaboration – a leader in academic research and a national women’s health nonprofit joined forces to amplify the power of women’s health research and investment. The collaborative symposium “From Discovery to Impact: Accelerating Women's Health Research Through Science, Policy, and Investment” hosted by Women’s Health Research at Yale and the Society for Women’s Health Research (SWHR) on June 15 in New Haven, Conn., welcomed more than 50 speakers, researchers from 28 departments across Yale, and gathered 350+ attendees for a day-long event that covered the power of women’s health research through an arc of discovery to practical impact.

Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab—recently approved for pediatric patients with Stage III type 1 diabetes—delays the progression of the disease.

A new Yale study reveals that your blood vessels operate as a coordinated signaling network—and uncovers the consequences of disrupting that network.

Two faculty members were honored for their mentorship of physician-scientists at the 2026 Janeway Society retreat.

Introducing Yale School of Medicine Department of Dermatology's Spring 2026 Annual Report! This inaugural edition features the latest updates in patient care, research, and education throughout the department over the last year.